Fractyl Laboratories’ Revita Study Reveals That Procedure Controls Type 2 Diabetes As Well As Invasive Bariatric Surgery Procedures
News
Fractyl Laboratories, Inc., a Waltham-based biotechnology company developing novel treatments for type 2 diabetes, recently announced data of a proof-of-concept, single-site trial in 39 patients, which determined that a minimally invasive surgical ... Read more